Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Trial Profile

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 04 Apr 2018

At a glance

  • Drugs Bedaquiline (Primary) ; Clofazimine (Primary) ; Ethambutol (Primary) ; Isoniazid (Primary) ; Levofloxacin (Primary) ; Linezolid (Primary) ; Pyrazinamide (Primary) ; Rifampicin (Primary) ; Rifapentine (Primary)
  • Indications Pulmonary tuberculosis
  • Focus Therapeutic Use
  • Acronyms TRUNCATE-TB
  • Most Recent Events

    • 27 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 26 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top